alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:42088

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-beta-D-glucosamine
beta-D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
Fuca1-2Galb1-4GlcNAcb
H type 2
H type II
human blood group H type 2 trisaccharide
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

An amino trisaccharide consisting of α-L-fucose, β-D-galactose and N-acetyl-β-D-glucosamine residues joined by sequential (1→2)- and (1→4)-linkages.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model